Mechanism of leukemia predisposition unraveled
Protein complex formed by ARID5B and its binding partners.
Mechanism of leukemia predisposition unraveled Read More »
Three research grants to strengthen precision medicine por pediatric cancer patients
Three research grants to strengthen precision medicine for pediatric cancer patients The Vienna Science and Technology Fund (WWTF) has funded three research projects on pediatric cancer in the same funding round—all of them including researchers at St. Anna CCRI. The projects, designed in collaboration with scientists at other Viennese and German institutions, aim to improve
Three research grants to strengthen precision medicine por pediatric cancer patients Read More »
Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine
Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine A computational scientist turned cancer researcher, Florian Halbritter is uncovering how developmental errors drive childhood cancer—work that has now earned him the Johann Wilhelm Ritter von Mannagetta Prize for Medicine from the Austrian Academy of Sciences (ÖAW). The award recognizes scientists under 45 working
Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine Read More »
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart (Vienna, 20.04.2026) – Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine have uncovered a new way to tackle acute myeloid leukemia (AML) cells in children: Instead of directly targeting
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart Read More »
Emerging Field Grant supports childhood cancer research
Emerging Field Grant supports childhood cancer research As part of the excellent=austria initiative, the Austrian Science Fund (FWF) is promoting innovative research collaborations in Austria through its Emerging Fields programme. Over the next five years, selected consortia will work to develop new, highly innovative research fields. Following a competitive international review process focusing on scientific
Emerging Field Grant supports childhood cancer research Read More »
Researchers decode cancer’s genetic control panel one DNA letter at a time
Researchers decode cancer’s genetic control panel one DNA letter at a time Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide
Researchers decode cancer’s genetic control panel one DNA letter at a time Read More »
Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development
Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development To study the molecular causes of pediatric cancer, scientists need to recreate complex developmental processes in the lab – an effort that often requires a great deal of trial and error. Scientists in the labs of Florian Halbritter and Davide Seruggia
St. Anna CCRI Symposium 2026: Bridging Developmental Biology and Childhood Cancer Research
St. Anna CCRI Symposium 2026: Bridging Developmental Biology and Childhood Cancer Research Last Friday, we hosted the second edition of the St. Anna CCRI Symposium. Organized by Principal Investigators Davide Seruggia, Polina Kameneva, and Florian Halbritter, this year’s symposium focused on Cell Fate in Cancer and Development. Childhood cancer often stems from developmental errors that cause cells to get stuck